Policy
More in Policy
COVID immunity through infection or vaccination: Are they equal?
As scientists argue whether a previous bout of covid offers the same amount of protection as vaccinations, people turn to the courts to decide.
Society news briefs: October 2021
Find out everything that’s been going on lately with the American Society for Biochemistry and Molecular Biology.
Collins’ skillful piloting helped NIH steer clear of political minefields
Francis Collins, who is stepping down as chief of the National Institutes of Health, used his communication skills and political insights to help protect the acclaimed federal research institutes through difficult times.
Tackling the growing problem of overmedication
Researchers and pharmacists are seeking solutions to this serious public health problem that disproportionately affects older adults.
Are COVID-19 boosters ethical, with half the world waiting for a first shot?
Scientists debate the medical benefits of booster shots. But there’s another aspect to consider: bioethics.
Scientists must speak out against 'immune-boosting' supplements
Supplements that claim to supercharge your T-cells, make your antibodies hum and otherwise make you invincible are all bunk, and scientists should speak out more about this misinformation.
Society news briefs: November 2021
More in Policy
Personal chemistry: Proteomics tackles privacy concerns
Sharing raw data is an important norm for the proteomics community. But as clinical studies become more detailed, researchers may need to clamp down to protect patient privacy.
What does full FDA approval of a vaccine do if it’s already authorized for emergency use?
While emergency use authorization gets vaccines out to the public more quickly, it doesn’t skip any steps that full approval requires.
Society news briefs
Find out everything that’s been going on lately with the American Society of Biochemistry and Molecular Biology.
Steps for getting started in science policy
“Science policy is a fast-paced field. You must be able to shift quickly between priorities and projects, sometimes in response to what’s going on that week in federal policy.”
Necessary or not, COVID booster shots are probably on the horizon
In today’s pharmaceutical universe, a simple “safe and effective” determination by the FDA to approve a drug can be manipulated to sell products of questionable value. And drugmakers can profit handsomely
US travel bans: Bizarre and ruthless
Continuing travel restrictions have prevented the author and thousands of other international scholars from seeing their families for a year and a half.
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.